Analysts Set DRI Healthcare Trust (TSE:DHT.UN) Target Price at C$17.94

DRI Healthcare Trust (TSE:DHT.UN) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is C$17.94.

A number of equities research analysts recently weighed in on DHT.UN shares. National Bankshares decreased their price objective on DRI Healthcare Trust from C$19.50 to C$17.50 and set an “outperform” rating for the company in a research note on Thursday, February 20th. CIBC decreased their price objective on DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a research note on Thursday, December 12th.

DRI Healthcare Trust Stock Performance

DHT.UN stock opened at C$11.68 on Friday. The business has a 50-day moving average price of C$11.96 and a 200 day moving average price of C$12.50. DRI Healthcare Trust has a 1-year low of C$10.39 and a 1-year high of C$17.43.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.